Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-24 @ 10:51 PM
NCT ID:
NCT01885169
Eligibility Criteria:
Inclusion Criteria:
* followed in one of the participating clinics
* considered in stable condition prior to enrollment as per their physician,
Exclusion Criteria:
* allergic to eggs or other vaccine components
* patients for whom LAIV is contraindicated (i.e. on oral steroids for an acute asthma exacerbation or with a medically-attended wheezing episode in the 7 days prior to immunization)
* participants with clinically significant nasal polyps
* have a significant febrile illness (oral temperature ≥ 380C) at day of vaccination
* pregnant women
* immunosuppressed subjects
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
18 Years
Study:
NCT01885169
Study Brief:
Protocol Section:
NCT01885169